Abstract
Streptococcus mutans is the main microorganism implied in dental caries. Different researches suggest that mutacins produced by this bacterium may be very important in the ability to exclude or preempt S. mutans establishment in the oral cavity. The aim of this study was to determine the mutacin production in the S. mutans strains isolated and biotyped from patients with and without dental caries. Unstimulated saliva was collected from 53 3 to 5-year-old children from the Diego Torres School in Turmequé (Boyacá, Colombia). Saliva samples were vortexed and serially diluted in 0.05 M phosphate buffer. Aliquots of the appropriate dilutions were cultured on Mitis Salivarius Bacitracin agar medium for the selective isolation of S. mutans, and incubated anaerobically for two days at 37°C. After, to the identification by biochemical tests, the strains isolated were biotyped with Api-ZYM enzymatic system (bioMérieux; Marcy-lE´toile, France). In order to determine the mutacins production, the strains were inoculated onto brain heart infusion agar (BHI). After a 48-hour CO2 incubation at 37°C, the plates were overlaid with 5 ml of 0,75% BHI agar containing 0.5 ml of an overnight BHI culture of the indicator strain. After additional 48 hours of CO2 incubation at 37oC the width of the inhibition zone was measured. The dental caries experience in these children was 66 (35/53) and S. mutans was found in the saliva of 33 children (62%). In the 33 strains of S. mutans 10 biotypes were found. The most frequent biotypes were the 10, 15 and the 11, respectively, with 9, 8 and 4 strains. Eight (24%) of the 33 evaluated strains produced mutacins, 6 of these strains came from patients with dental caries and the other two from patients without dental caries. The 8 strains which produced mutacins presented 5 different biotypes: 3 strains with biotype 10, 2 strains with biotype 14, and the last three ones were, respectively, biotypes 11, 15, and 17. The obtained results in this study are in agreement with the information reported in other works done with S. mutans. Conclusions: In the 33 strains of S. mutans evaluated, 8 strains (24%) which produced mutacins with 5 different biotypes were identified, which after accomplishing other requirements have a great option to be used in oral infections control in which S. mutans is involved.
Herazo B. Morbilidad bucodental colombiana: Universidad Nacional de Colombia y Ministerio de Salud. Bogotá: Ediciones Ecoe; 1995.
Loesche WJ. Role de Streptococcus mutans in human dental decay . Microbiol Rev 1986; 50: 353-80.
Lang NP, Hotz PR, Gusberti FA, Joss A. Longitudinal clinical and microbiological study on the relationship between infection with Streptococcus mutans and the development of caries in human. Oral Microbiol Immnunol 1987; 2: 39-47.
Beighton D, Manji F, Baelum V, Fejerskov O, Johnson NW, Wilton JM. Associations between salivary levels of Streptococcus mutans , Streptococcus sobrinus , lactobacilli, and caries experience in Kenyan adolescents. J Dent Res 1989; 68: 1242-6.
van Houte J, Sansone C, Joshipura K, Kent R. Mutans streptococci and non-mutans streptococci acidogenic at low pH, and in vitro acidogenic potential of dental plaque in two different areas of the human dentition . J Dent Res 1991; 70: 1503-7.
Gamboa F, Herazo B, Martínez MC. Control mi- crobiológico sobre Streptococcus mutans y su acción acidogénica. Univers Scient 2004; 9: 45- 55.
Hamada S, Slade HD. Biology, immunology and cariogenicity of Streptococcus mutans . Microbiol Rev 1980; 44: 331-84.
Hamada S, Ooshima T. Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Arch Oral Biol 1975; 20: 641-48.
Rogers AH. Bacteriogeny and the properties of some bacteriocins of Streptococcus mutans. Arch Oral Biol 1976; 21: 99-104.
Kamiya RU, Napimoga MH, Rosa RT, Höfling JF, Goncalves RB. Mutacin production in Streptococcus mutans genotypes isolated from caries-affected and caries-free individuals . Oral Microbiol Immunol 2005; 20: 20-4.
Tagg JR, Dajani AS, Wannamaker LW. Bacteriocin of gram-positive . Bacteriol Rev 1976; 40: 722- 56.
Hillman JD; Dzuback AL, Andrews SW. Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin . J Dent Res 1987; 66: 1092-4.
Hillman JD, Johnson KP, Yaphe BI. Isolation of a Streptococcus mutans strains producing a novel bacteriocin. Infect Immun 1984; 44: 141-4.
Rogers AH, van der Hoeven JS, Mikx FHM. Effect of bacteriocin production by Streptococcus mutans on the plaque of gnotobiotic rats. Infect Immun 1979; 23: 571-6.
Fabio U, Bondi M, Manicardi G, Messi P, Neglia R. Production of bacteriocin-like substances by human oral streptococci. Microbiológica 1987; 10: 363-70.
Fure S. Five year incidence of caries, salivary and microbial conditions in 60-, 70- and 80-year- old swedish individuals. Caries Res 1988; 32: 166-74.
Emilson CG. Prevalence of Streptococcus mutans with different colonial morphologies in human plaque and saliva. Scandinavan J Dent Res 1981; 91: 26-32.
Lamby CP, Gamboa F, Chaves M, Valdivieso C. Fenotipificación bioquímica del Streptococcus mutans en cavidad bucal en población escolar de Cota, Cundinamarca. Tribuna Odontol 2005; 2: 73-7.
Dykes GA. Bacteriocins: ecological and evolutionary significance . Trends Ecol Evol 1995; 10: 186-9.
Hillman JD, Socransky SS. Replacement therapy for the prevention of dental disease. Adv Dent Res 1987; 1: 119-25.
Hillman JD, Brooks TA, Michalek SM, Harmon CC, Snoep JL, van Der Weijden CC. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries . Infect Immun 2000; 68: 543-9.
Balakrishnan M, Simmonds RS, Tagg JR. Diverse activity spectra of bacteriocin-like inhibitory substances having activity against Mutans Streptococci , Caries Res 2001; 35: 75-80.
Weerkampp A, Bongaerts-Larik L, Vogels GD. Bacteriocins as factors in the in vitro interaction between oral streptococci in plaque. Infect Immun 1977; 16: 773-80.
van der Hoeven JS, Roger AH. Stability of the resident microflora and the bacteriocinogenicity of Streptococcus mutans as factors affecting its establishment in specific pathogen-free rats . Infect Immun 1979; 23: 206-12.
Kamiya RU, Napimoga MH, Rosa RT, Höfling JF, Goncalves RB. Mutacin production in Streptococcus mutans genotypes isolated from caries-affected and caries-free individuals. Oral Microbiol Immunol 2005; 20: 20-4.
de La Higuera Angustias, Gutiérrez J, Liébana J, García-Mendoza A, Castillo A. A new biotyping method for Streptococcus mutans with the api-ZYM system. Clin Microbiol Infect 1999; 5: 88-91.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.